Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QTP-102
- Development stage
- Preclinical
- Lead developer
- Quratis
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
QTP-102 is a preclinical-stage vaccine candidate being developed by Quratis for the prevention of tuberculosis (TB). The program is supported by the RIGHT Foundation (Research Investment for Global Health Technology Foundation). As part of Quratis's infectious disease pipeline, QTP-102 represents a non-clinical effort to expand immunization options against Mycobacterium tuberculosis, complementing the company's more advanced clinical-stage TB vaccine candidates like QTP101. While specific details regarding the vaccine platform (such as whether it is a subunit, viral vector, or nucleic acid-based vaccine) are not publicly detailed in high-level pipeline summaries, the asset is positioned to address global health needs in TB prevention.
02
Targets
Antigen-specific B-cell receptor (BCR) recognizing ESAT-6 and Rv2299c epitopesTCR-ESAT-6/Rv2299c (Antigen-specific T-cell receptor recognizing ESAT-6 and Rv2299c peptides)STING (Stimulator of interferon genes protein)TLR4 (Toll-like receptor 4)
Beyond the preview
Go deeper on QTP-102.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QTP-102.